Analysis of positional candidate genes in the AAA1 susceptibility locus for abdominal aortic aneurysms on chromosome 19

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Lillvis, John H ^a   Kyo, Yoshiki ^a,h   Tromp, Gerard ^b   Lenk, Guy M ^a,i   Li, Ming ^c   Lu, Qing ^c,d   Igo Jr, Robert P ^d   Sakalihasan, Natzi ^e   Ferrell, Robert E ^f   Schworer, Charles M ^b   Gatalica, Zoran ^g   Land, Susan ^a   Kuivaniemi, Helena ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEIS CENTER FOR RESEARCH   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h National Hospital Organization Higashihiroshima Medical Center   (Japan)

ⁱ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CCAAT ENHANCER BINDING PROTEIN; CD22 ANTIGEN; DNA; MESSENGER RNA; PROLINE DIPEPTIDASE; CCAAT ENHANCER BINDING PROTEIN GAMMA; CCAAT-ENHANCER-BINDING PROTEIN-GAMMA; CD22 PROTEIN, HUMAN; DIPEPTIDASE;

3' UNTRANSLATED REGION; ABDOMINAL AORTA ANEURYSM; ADVENTITIA; ANTIBODY SPECIFICITY; AORTA; AORTA WALL; ARTICLE; CHROMOSOME 19; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC DATABASE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MULTICENTER STUDY; MYOFIBROBLAST; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SECTION; ABDOMINAL AORTA; AGED; CASE CONTROL STUDY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ANTIGENS, CD22; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; CASE-CONTROL STUDIES; CCAAT-ENHANCER-BINDING PROTEINS; CHROMOSOMES, HUMAN, PAIR 19; DIPEPTIDASES; EXONS; FEMALE; FIBROBLASTS; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78651498914     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-14     Document Type: Article

References (67)

1. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, Barone GW, Bandyk D, Moneta GL, Makhoul RG. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 2000, 160:1425-1430. 10.1001/archinte.160.10.1425, 10826454.
2. Keeling WB, Armstrong PA, Stone PA, Bandyk DF, Shames ML. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 2005, 39:457-464. 10.1177/153857440503900601, 16382266.
3. Liu J, Sukhova GK, Yang JT, Sun J, Ma L, Ren A, Xu WH, Fu H, Dolganov GM, Hu C, et al. Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis 2006, 184:302-311. 10.1016/j.atherosclerosis.2005.05.012, 15982660.
4. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998, 102:576-583. 10.1172/JCI181, 508918, 9691094.
5. Chamberlain CM, Ang LS, Boivin WA, Cooper DM, Williams SJ, Zhao H, Hendel A, Folkesson M, Swedenborg J, Allard MF, et al. Perforin-independent extracellular granzyme B activity contributes to abdominal aortic aneurysm. Am J Pathol 2010, 176:1038-1049. 10.2353/ajpath.2010.090700, 2808106, 20035050.
6. Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson PG, Pearce WH. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990, 137:1199-1213. 1877681, 1700620.
7. Kuivaniemi H, Platsoucas CD, Tilson MD. Aortic aneurysms: an immune disease with a strong genetic component. Circulation 2008, 117:242-252. 10.1161/CIRCULATIONAHA.107.690982, 3001294, 18195185.
8. Nischan J, Lenk GM, Boddy AM, Lillvis JH, Tromp G, Kuivaniemi H. Abdominal aortic aneurysms- a complex genetic disease. Aneurysms: Types, Risks, Formation and Treatment 2009, NY: Nova Science Publishers, Inc, Laurent A, Morel E. Hauppage.
9. Hinterseher I, Tromp G, Kuivaniemi H. Genes and Abdominal Aortic Aneurysm. Ann Vasc Surg 2010,
10. Lillvis JH, Lenk GM, Kuivaniemi H. Genetics of Abdominal Aortic Aneurysms. Aortic Aneurysms: Pathogenesis and Treatment 2008, 1-26. Totowa, NJ: Humana Press Inc, Upchurch G, Criado E.
11. Gretarsdottir S, Baas AF, Thorleifsson G, Holm H, den Heijer M, de Vries JP, Kranendonk SE, Zeebregts CJ, van Sterkenburg SM, Geelkerken RH, et al. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet 2010, 42:692-697. 10.1038/ng.622, 20622881.
12. Helgadottir A, Thorleifsson G, Magnusson KP, Grétarsdottir S, Steinthorsdottir V, Manolescu A, Jones GT, Rinkel GJ, Blankensteijn JD, Ronkainen A, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008, 40:217-224. 10.1038/ng.72, 18176561.
13. Jones GT, Thompson AR, van Bockxmeer FM, Hafez H, Cooper JA, Golledge J, Humphries SE, Norman PE, van Rij AM. Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler Thromb Vasc Biol 2008, 28:764-770. 10.1161/ATVBAHA.107.155564, 2775049, 18239157.
14. McColgan P, Peck GE, Greenhalgh RM, Sharma P. The genetics of abdominal aortic aneurysms: a comprehensive meta-analysis involving eight candidate genes in over 16,700 patients. Int Surg 2009, 94:350-358.
15. Shibamura H, Olson JM, van Vlijmen-Van Keulen C, Buxbaum SG, Dudek DM, Tromp G, Ogata T, Skunca M, Sakalihasan N, Pals G, et al. Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13. Circulation 2004, 109:2103-2108. 10.1161/01.CIR.0000127857.77161.A1, 15096456.
16. van Vlijmen-van Keulen CJ, Rauwerda JA, Pals G. Genome-wide linkage in three Dutch families maps a locus for abdominal aortic aneurysms to chromosome 19q13.3. Eur J Vasc Endovasc Surg 2005, 30:29-35. 10.1016/j.ejvs.2004.12.029, 15933979.
17. Olson JM, Vongpunsawad S, Kuivaniemi H, Ronkainen A, Hernesniemi J, Ryynanen M, Kim LL, Tromp G. Search for intracranial aneurysm susceptibility gene(s) using Finnish families. BMC Med Genet 2002, 3:7. 10.1186/1471-2350-3-7, 119849, 12153705.
18. van der Voet M, Olson JM, Kuivaniemi H, Dudek DM, Skunca M, Ronkainen A, Niemela M, Jaaskelainen J, Hernesniemi J, Helin K, et al. Intracranial aneurysms in Finnish families: confirmation of linkage and refinement of the interval to chromosome 19q13.3. Am J Hum Genet 2004, 74:564-571. 10.1086/382285, 1182270, 14872410.
19. Yamada S, Utsunomiya M, Inoue K, Nozaki K, Inoue S, Takenaka K, Hashimoto N, Koizumi A. Genome-wide scan for Japanese familial intracranial aneurysms: linkage to several chromosomal regions. Circulation 2004, 110:3727-3733. 10.1161/01.CIR.0000143077.23367.18, 15569837.
20. Onouchi Y, Tamari M, Takahashi A, Tsunoda T, Yashiro M, Nakamura Y, Yanagawa H, Wakui K, Fukushima Y, Kawasaki T, Hata A. A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J Hum Genet 2007, 52:179-190. 10.1007/s10038-006-0092-3, 17160344.
21. Surazynski A, Miltyk W, Palka J, Phang JM. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids 2008, 35:731-738. 10.1007/s00726-008-0051-8, 18320291.
22. Nitschke L. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol Rev 2009, 230:128-143. 10.1111/j.1600-065X.2009.00801.x, 19594633.
23. Hitomi Y, Tsuchiya N, Hasegawa M, Fujimoto M, Takehara K, Tokunaga K, Sato S. Association of CD22 gene polymorphism with susceptibility to limited cutaneous systemic sclerosis. Tissue Antigens 2007, 69:242-249. 10.1111/j.1399-0039.2007.00801.x, 17493148.
24. Ogata T, Gregoire L, Goddard KA, Skunca M, Tromp G, Lancaster WD, Parrado AR, Lu Q, Shibamura H, Sakalihasan N, et al. Evidence for association between the HLA-DQA locus and abdominal aortic aneurysms in the Belgian population: a case control study. BMC Med Genet 2006, 7:67. 10.1186/1471-2350-7-67, 1559600, 16879749.
25. Ogata T, Shibamura H, Tromp G, Sinha M, Goddard KA, Sakalihasan N, Limet R, MacKean GL, Arthur C, Sueda T, et al. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg 2005, 41:1036-1042. 10.1016/j.jvs.2005.02.020, 1249499, 15944607.
26. Dean FB, Hosono S, Fang L, Wu X, Faruqi AF, Bray-Ward P, Sun Z, Zong Q, Du Y, Du J, et al. Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci USA 2002, 99:5261-5266. 10.1073/pnas.082089499, 122757, 11959976.
27. Tromp G, Wu Y, Prockop DJ, Madhatheri SL, Kleinert C, Earley JJ, Zhuang J, Norrgard O, Darling RC, Abbott WM, et al. Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms. J Clin Invest 1993, 91:2539-2545. 10.1172/JCI116490, 443315, 8514866.
28. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25:25-29. 10.1038/75556, 10802651.
29. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30. 10.1093/nar/28.1.27, 102409, 10592173.
30. Lenk GM, Tromp G, Weinsheimer S, Gatalica Z, Berguer R, Kuivaniemi H. Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 2007, 8:237. 10.1186/1471-2164-8-237, 1934369, 17634102.
31. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150. 10.1093/bioinformatics/19.1.149, 12499305.
32. Steemers FJ, Gunderson KL. Illumina, Inc. Pharmacogenomics 2005, 6:777-782. 10.2217/14622416.6.7.777, 16207153.
33. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005, 76:887-893. 10.1086/429864, 1199378, 15789306.
34. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
35. S.A.G.E Statistical Analysis for Genetic Epidemiology. 2009, Cleveland: Department of Epidemiology and Biostatistics, Case Western Reserve University, Release 6.0.1 edition.
36. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002, 70:425-434. 10.1086/338688, 384917, 11791212.
37. Rozen S, Skaletsky H. Primer3 on the www for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
38. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 2003, 31:3812-3814. 10.1093/nar/gkg509, 168916, 12824425.
39. Blom N, Gammeltoft S, Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 1999, 294:1351-1362. 10.1006/jmbi.1999.3310, 10600390.
40. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-144. 10.1093/nar/gkj112, 1347474, 16381832.
41. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-158. 10.1093/nar/gkm952, 2238936, 17991681.
42. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
43. Pearce WH, Koch AE. Cellular components and features of immune response in abdominal aortic aneurysms. Ann N Y Acad Sci 1996, 800:175-185. 10.1111/j.1749-6632.1996.tb33308.x, 8958992.
44. Stella A, Gargiulo M, Pasquinelli G, Preda P, Faggioli GL, Cenacchi G, D'Addato M. The cellular component in the parietal infiltrate of inflammatory abdominal aortic aneurysms (IAAA). Eur J Vasc Surg 1991, 5:65-70. 10.1016/S0950-821X(05)80929-6, 2009988.
45. Walton LJ, Powell JT, Parums DV. Unrestricted usage of immunoglobulin heavy chain genes in B cells infiltrating the wall of atherosclerotic abdominal aortic aneurysms. Atherosclerosis 1997, 135:65-71. 10.1016/S0021-9150(97)00152-4, 9395274.
46. Lupi A, Tenni R, Rossi A, Cetta G, Forlino A. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations. Amino Acids 2008, 35:739-752. 10.1007/s00726-008-0055-4, 18340504.
47. Surazynski A, Liu Y, Miltyk W, Phang JM. Nitric oxide regulates prolidase activity by serine/threonine phosphorylation. J Cell Biochem 2005, 96:1086-1094. 10.1002/jcb.20631, 16167338.
48. Duong HS, Zhang QZ, Le AD, Kelly AP, Kamdar R, Messadi DV. Elevated prolidase activity in keloids: correlation with type I collagen turnover. Br J Dermatol 2006, 154:820-828. 10.1111/j.1365-2133.2006.07167.x, 16634881.
49. Baxter BT, Davis VA, Minion DJ, Wang YP, Lynch TG, McManus BM. Abdominal aortic aneurysms are associated with altered matrix proteins of the nonaneurysmal aortic segments. J Vasc Surg 1994, 19:797-802.
50. Deguchi JO, Huang H, Libby P, Aikawa E, Whittaker P, Sylvan J, Lee RT, Aikawa M. Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II. Lab Invest 2009, 89:315-326. 10.1038/labinvest.2008.167, 2932654, 19153555.
51. Lizarbe TR, Tarin C, Gomez M, Lavin B, Aracil E, Orte LM, Zaragoza C. Nitric oxide induces the progression of abdominal aortic aneurysms through the matrix metalloproteinase inducer EMMPRIN. Am J Pathol 2009, 175:1421-1430. 10.2353/ajpath.2009.080845, 2751539, 19779140.
52. Karna E, Palka J, Wolczynski S. Doxycycline-induced inhibition of prolidase activity in human skin fibroblasts and its involvement in impaired collagen biosynthesis. Eur J Pharmacol 2001, 430:25-31. 10.1016/S0014-2999(01)01372-3, 11698059.
53. Abdul-Hussien H, Hanemaaijer R, Verheijen JH, van Bockel JH, Geelkerken RH, Lindeman JH. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content. J Vasc Surg 2009, 49:741-749. 10.1016/j.jvs.2008.09.055, 19268776.
54. Baxter BT, Pearce WH, Waltke EA, Littooy FN, Hallett JW, Kent KC, Upchurch GR, Chaikof EL, Mills JL, Fleckten B, et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg 2002, 36:1-12. 10.1067/mva.2002.125018, 12096249.
55. Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM, Sicard GA, Thompson RW. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 2000, 31:325-342. 10.1016/S0741-5214(00)90163-0, 10664501.
56. Lindeman JH, Abdul-Hussien H, van Bockel JH, Wolterbeek R, Kleemann R. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation 2009, 119:2209-2216. 10.1161/CIRCULATIONAHA.108.806505, 19364980.
57. Miltyk W, Anchim T, Wolczynski S, Palka J. Estrogen-dependent regulation of prolidase activity in breast cancer MCF-7 cells. Gynecol Endocrinol 1999, 13:166-174. 10.3109/09513599909167551, 10451808.
58. Wolczynski S, Surazynski A, Swiatecka J, Palka J. Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells. Gynecol Endocrinol 2001, 15:225-233.
59. Cakmak A, Zeyrek D, Atas A, Celik H, Aksoy N, Erel O. Serum prolidase activity and oxidative status in patients with bronchial asthma. J Clin Lab Anal 2009, 23:132-138. 10.1002/jcla.20303, 19288447.
60. Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, Aksoy N, Ocak AR, Erel O. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis 2008, 19:319-325. 10.1097/MCA.0b013e32830042ba, 18607169.
61. Kayadibi H, Gultepe M, Yasar B, Ince AT, Ozcan O, Ipcioglu OM, Kurdas OO, Bolat B, Benek YZ, Guveli H, et al. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis. Dig Dis Sci 2009, 54:1764-1771. 10.1007/s10620-008-0535-0, 18989777.
62. Odaka M, Hasegawa M, Hamaguchi Y, Ishiura N, Kumada S, Matsushita T, Komura K, Sato S, Takehara K, Fujimoto M. Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis. Clin Exp Immunol 2010, 159:176-184. 10.1111/j.1365-2249.2009.04059.x, 2810386, 19919568.
63. Tang T, Boyle JR, Dixon AK, Varty K. Inflammatory abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2005, 29:353-362.
64. Nitecki SS, Hallett JW, Stanson AW, Ilstrup DM, Bower TC, Cherry KJ, Gloviczki P, Pairolero PC. Inflammatory abdominal aortic aneurysms: a case-control study. J Vasc Surg 1996, 23:860-868. 10.1016/S0741-5214(96)70249-5, 8667508.
65. Baas AF, Medic J, van't Slot R, de Vries JP, van Sambeek MR, Geelkerken BH, Boll BP, Grobbee DE, Wijmenga C, Ruigrok YM, Blankensteijn JD. Association Study of Single Nucleotide Polymorphisms on Chromosome 19q13 With Abdominal Aortic Aneurysm. Angiology 2010, 61:243-247. 10.1177/0003319709354752, 20156811.
66. Rehman AU, Morell RJ, Belyantseva IA, Khan SY, Boger ET, Shahzad M, Ahmed ZM, Riazuddin S, Khan SN, Friedman TB. Targeted capture and next-generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79. Am J Hum Genet 2010, 86:378-388. 10.1016/j.ajhg.2010.01.030, 2833391, 20170899.
67. Rosa-Rosa JM, Gracia-Aznarez FJ, Hodges E, Pita G, Rooks M, Xuan Z, Bhattacharjee A, Brizuela L, Silva JM, Hannon GJ, Benitez J. Deep sequencing of target linkage assay-identified regions in familial breast cancer: methods, analysis pipeline and troubleshooting. PLoS One 2010, 5:e9976. 10.1371/journal.pone.0009976, 2848842, 20368986.